The (pro)renin receptor: pathophysiological roles in cardiovascular and renal pathology
- 1 March 2007
- journal article
- review article
- Published by Wolters Kluwer Health in Current Opinion in Nephrology and Hypertension
- Vol. 16 (2) , 129-133
- https://doi.org/10.1097/mnh.0b013e328040bfab
Abstract
The pathophysiological role of the (pro)renin receptor is yet to be established. The present review summarizes the findings, suggesting that it may play pathological role in cardiac and renal fibrosis, and in hypertensive and diabetic nephropathy.In-vitro and animal studies have shown that increased receptor expression could be linked to high blood pressure and to cardiac and glomerular fibrosis by activating mitogen-activated protein kinases and by upregulating gene expression of profibrotic molecules. Studies also suggest that the receptor is involved in diabetic nephropathy by activating receptor-bound prorenin, thereby increasing angiotensin II tissue generation. Moreover, in diabetic mice, a peptide able to block prorenin binding to the receptor was claimed to be more effective for renal protection than angiotensin-converting enzyme inhibitor.The experimental data confirmed the pivotal role of the receptor in cell surface generation of angiotensin and suggested its potential role in tissue fibrosis via receptor activation and intracellular signaling. The data also questioned the ability of soon available renin inhibitors to inhibit the activity of receptor-bound renin and prorenin, and the benefit of a new class of drug--(pro)renin receptor blockers--to prevent tissue damage.Keywords
This publication has 21 references indexed in Scilit:
- Contribution of Nonproteolytically Activated Prorenin in Glomeruli to Hypertensive Renal DamageJournal of the American Society of Nephrology, 2006
- Prorenin Receptor Blockade Inhibits Development of Glomerulosclerosis in Diabetic Angiotensin II Type 1a Receptor–Deficient MiceJournal of the American Society of Nephrology, 2006
- Nonproteolytic Activation of Prorenin Contributes to Development of Cardiac Fibrosis in Genetic HypertensionHypertension, 2006
- Inhibition of diabetic nephropathy by a decoy peptide corresponding to the “handle” region for nonproteolytic activation of proreninJournal of Clinical Investigation, 2004
- Human Prorenin Has “Gate and Handle” Regions for Its Non-proteolytic ActivationJournal of Biological Chemistry, 2003
- Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to reninJournal of Clinical Investigation, 2002
- Prorenin-Induced Myocyte ProliferationHypertension, 2002
- Prorenin Accumulation and Activation in Human Endothelial CellsArteriosclerosis, Thrombosis, and Vascular Biology, 2001
- Mannose 6-Phosphate Receptor–Mediated Internalization and Activation of Prorenin by Cardiac CellsHypertension, 1997
- Specific receptor binding of renin on human mesangial cells in culture increases plasminogen activator inhibitor-1 antigenKidney International, 1996